Drug profile · INN
dinutuximab
UNITUXIN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dinutuximab (UNITUXIN) is an FDA-listed pharmaceutical active ingredient. Associated with United Therapeutics Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN dinutuximab
Brand UNITUXIN
Route INTRAVENOUS
Formulation INJECTABLE
ATC code L01FX06
Originator United Therapeutics Europe Ltd
Frequently asked questions
What is dinutuximab?
dinutuximab (UNITUXIN) is an FDA-listed pharmaceutical active ingredient. Associated with United Therapeutics Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for dinutuximab?
UNITUXIN is a marketed brand name for dinutuximab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dinutuximab?
dinutuximab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.